Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Moeller, Benjamin J, Chintagumpala, Murali, Philip, Jimmy J, Grosshans, David R, McAleer, Mary F, Woo, Shiao Y, Gidley, Paul W, Vats, Tribhawan S, Mahajan, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://www.ncbi.nlm.nih.gov/pubmed/21635776
http://dx.doi.org/10.1186/1748-717X-6-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://www.ncbi.nlm.nih.gov/pubmed/21635776
http://dx.doi.org/10.1186/1748-717X-6-58

Ejemplares similares